Dextrose 5%
NMRR-14-950-20443
Approved small_molecule active
Quick answer
Dextrose 5% for End-Stage Kidney Disease is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- End-Stage Kidney Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- active